REGULUS THERAPEUTICS

Serial Number 77329824
606

Registration Progress

Application Filed
Nov 14, 2007
Under Examination
Jun 2, 2009
Approved for Publication
Feb 18, 2009
Published for Opposition
Mar 10, 2009
Registered

Trademark Image

REGULUS THERAPEUTICS

Basic Information

Serial Number
77329824
Filing Date
November 14, 2007
Published for Opposition
March 10, 2009
Abandonment Date
July 2, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 2, 2012
Classes
005

Rights Holder

REGULUS THERAPEUTICS INC.

03
Address
1896 RUTHERFORD ROAD
CARLSBAD, CA 920087208

Ownership History

Regulus Therapeutics LLC

Original Applicant
16
Carlsbad, CA

REGULUS THERAPEUTICS INC.

New Owner Before Publication #1
03
CARLSBAD, CA

REGULUS THERAPEUTICS INC.

Owner at Publication
03
CARLSBAD, CA

Legal Representation

Attorney
Gretchen R. Stroud

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Oct 17, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 2, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 2, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 2, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2011 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 29, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 29, 2011 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 27, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 26, 2011 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 25, 2011 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 25, 2011 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 25, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 24, 2010 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 22, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 22, 2010 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 13, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2010 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 9, 2010 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 9, 2010 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 30, 2009 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 24, 2009 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 24, 2009 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 17, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 17, 2009 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 21, 2009 MAIL I PAPER RECEIVED Loading...
Jun 2, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 10, 2009 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 18, 2009 NPUB O NOTICE OF PUBLICATION Loading...
Feb 2, 2009 ALIE A ASSIGNED TO LIE Loading...
Feb 2, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 28, 2009 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jan 21, 2009 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jan 21, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 21, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 21, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 27, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 27, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 27, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 27, 2008 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 27, 2008 GRML O CORRESPONDENCE E-MAILED Loading...
Aug 27, 2008 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 27, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 27, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 27, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 27, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 19, 2007 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological, muscular, fibrotic and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"